Proteomic Assessment of Extracellular Vesicles from Canine Tissue Explants as a Pipeline to Identify Molecular Targets in Osteosarcoma: PSMD14/Rpn11 as a Proof of Principleopen access
- Authors
- Luu, Anita K; Cadieux, Mia; Wong, Mackenzie; Macdonald, Rachel; Jones, Robert; Choi, Dongsic; Oblak, Michelle; Brisson, Brigitte; Sauer, Scott; Chafitz, James; Warshawsky, David; Wood, Geoffrey A; Viloria-Petit, Alicia M
- Issue Date
- Mar-2022
- Publisher
- Multidisciplinary Digital Publishing Institute (MDPI)
- Keywords
- osteosarcoma; extracellular vesicles; tissue explants; biomarker discovery; molecular targets
- Citation
- International Journal of Molecular Sciences, v.23, no.6, pp 1 - 25
- Pages
- 25
- Journal Title
- International Journal of Molecular Sciences
- Volume
- 23
- Number
- 6
- Start Page
- 1
- End Page
- 25
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/20574
- DOI
- 10.3390/ijms23063256
- ISSN
- 1661-6596
1422-0067
- Abstract
- Osteosarcoma (OS) is a highly malignant bone tumour that has seen little improvement in treatment modalities in the past 30 years. Understanding what molecules contribute to OS biology could aid in the discovery of novel therapies. Extracellular vesicles (EVs) serve as a mode of cell-to-cell communication and have the potential to uncover novel protein signatures. In our research, we developed a novel pipeline to isolate, characterize, and profile EVs from normal bone and osteosarcoma tissue explants from canine OS patients. Proteomic analysis of vesicle preparations revealed a protein signature related to protein metabolism. One molecule of interest, PSMD14/Rpn11, was explored further given its prognostic potential in human and canine OS, and its targetability with the drug capzimin. In vitro experiments demonstrated that capzimin induces apoptosis and reduces clonogenic survival, proliferation, and migration in two metastatic canine OS cell lines. Capzimin also reduces the viability of metastatic human OS cells cultured under 3D conditions that mimic the growth of OS cells at secondary sites. This unique pipeline can improve our understanding of OS biology and identify new prognostic markers and molecular targets for both canine and human OS patients.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Biochemistry > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/20574)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.